Fox Run Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,571
Closed -$298K 1193
2025
Q4
$298K Sell
28,571
-702
-2% -$7.04K 0.05% 701
2025
Q3
$263K Buy
+29,273
New +$257K 0.04% 728
2025
Q2
Sell
-10,161
Closed -$257K 1178
2025
Q1
$257K Sell
10,161
-19,297
-66% -$573K 0.04% 722
2024
Q4
$1.01M Buy
29,458
+9,443
+47% +$426K 0.18% 152
2024
Q3
$989K Buy
+20,015
New +$1.03M 0.22% 128
2024
Q2
Sell
-11,346
Closed -$585K 1032
2024
Q1
$585K Sell
11,346
-532
-4% -$26.1K 0.13% 309
2023
Q4
$479K Buy
+11,878
New +$348K 0.12% 320

Other funds holding RXST

Fox Run Management's RXST Position: Q1 2026 in Review

Fox Run Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 28,571 shares — an estimated $298K sold.

Fox Run Management first reported a position in RXST in Q4 2023 and held it in 7 quarters. The position peaked at $1.01M in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Fox Run Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 28,571 RxSight shares in Q1 2026, an estimated $298K.
  • Fox Run Management first reported a position in RxSight in Q4 2023 and held it in 7 quarters.
  • Fox Run Management's RxSight position peaked at $1.01M in Q4 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.